Long-term entecavir (ETV) therapy improves liver stiffness measurements (LSMs) in patients with HBeAg-negative chronic hepatitis B (CHB)

被引：0
|
作者：
Papatheodoridis, George V. [1 ]
Goulis, Ioannis [2 ]
Manolakopoulos, Spilios [1 ]
Margariti, Katerina [1 ]
Exarchos, Xenofon [2 ]
Kokkonis, George [2 ]
Papaioannou, Christos [1 ]
Akriviadis, Evangelos A. [2 ]
机构：
[1] Hippokrateion Hosp, Dept Internal Med 2, Athens, Greece
[2] Aristotle Univ Thessaloniki, Dept Med 4, Hippokrat Gen Hosp, GR-54006 Thessaloniki, Greece
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
384
引用
收藏
页码：380A / 380A
页数：1
相关论文
共 50 条
  • [1] HISTOLOGIC ASSESSMENT OF LONG-TERM ENTECAVIR (ETV) TREATMENT IN CHRONIC HEPATITIS B (CHB) PATIENTS
    Katano, Yoshiaki
    Kumada, Hiromitsu
    Kobashi, Haruhiko
    Toyoto, Joji
    Yokosuka, Osamu
    Takaguchi, Koichi
    Kage, Masayoshi
    Moriyama, Mitsuhiko
    Imozeki, Furnio
    Ishikawa, Hiroki
    Seriu, Toku
    Omota, Masao
    HEPATOLOGY, 2008, 48 (04) : 703A - 704A
  • [2] Discontinuation of long-term NA therapy in HBeAg-negative chronic hepatitis B
    Hadziyannis, Stephanos
    Liaw, Yun-Fan
    GUT, 2015, 64 (06) : 1005 - 1006
  • [3] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Ma, J
    Arterburn, S
    Xiong, S
    Currie, G
    Brosgart, CL
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2673 - 2681
  • [4] LONG-TERM OUTCOME IN NON-CIRRHOTIC PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHB) WHO STOPPED ENTECAVIR (ETV) OR TENOFOVIR (TDF) THERAPY. FINAL RESULTS OF A MULTICENTER PROSPECTIVE STUDY
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Kourikou, Anastasia
    Triantos, Christos
    Manesis, Emanuel K.
    Mathou, Nikoletta
    Alexopoulou, Alexandra
    Deutsch, Melanie
    Hadziyannis, Emilia
    Papatheodoridis, George
    GASTROENTEROLOGY, 2020, 158 (06) : S1319 - S1319
  • [5] Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    Lai, CL
    Shouval, D
    Lok, AS
    Chang, TT
    Cheinquer, H
    Goodman, Z
    DeHertogh, D
    Wilber, R
    Zink, RC
    Cross, A
    Colonno, R
    Fernandes, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1011 - 1020
  • [6] The impact of interferon-alfa (IFNa) therapy on liver histology in patients with HBeAg-negative chronic hepatitis B [HBeAg(-)CHB].
    Papatheodoridis, GV
    Cholongitas, E
    Kanta, E
    Petraki, K
    Ketikoglou, I
    Manesis, EK
    HEPATOLOGY, 2003, 38 (04) : 712A - 712A
  • [7] Long term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Bhushan, B.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S95 - S95
  • [8] PROFOUND VIROLOGIC RESPONSE IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH ENTECAVIR (ETV) IN HBEAG POSITIVE AND NEGATIVE DISEASE
    Baqai, Sumbella F.
    Yi, Debbie Hana
    Gish, Robert G.
    HEPATOLOGY, 2009, 50 (04) : 530A - 530A
  • [9] Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure
    Jing Lai
    Ying Yan
    Li Mai
    Yu-Bao Zheng
    Wei-Qiang Gan
    Wei-Min Ke
    Hepatobiliary&PancreaticDiseasesInternational, 2013, 12 (02) : 154 - 159
  • [10] Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure
    Lai, Jing
    Yan, Ying
    Mai, Li
    Zheng, Yu-Bao
    Gan, Wei-Qiang
    Ke, Wei-Min
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2013, 12 (02) : 154 - 159
12345